AstraZeneca wagers $200M on Ionis' next chance at a rare disease drug

Submitted by admin on December 7, 2021 - 10:48am

Source:

BioPharma Dive

News Tags:

AstraZeneca

Ionis Pharmaceuticals

transthyretin amyloidosis

eplontersen

Headline:

AstraZeneca wagers $200M on Ionis' next chance at a rare disease drug

snippet:

AstraZeneca has acquired rights to an experimental Ionis Pharmaceuticals drug in advanced clinical testing for the rare disease transthyretin amyloidosis, the company announced Tuesday.

Search form

You are here

AstraZeneca wagers $200M on Ionis' next chance at a rare disease drug

AstraZeneca wagers $200M on Ionis' next chance at a rare disease drug